MST1R and gallbladder cancer: Given that the IC50 values of MGCD-265 were consistently below 1 μM for all three types of gallbladder cancer cells, it strongly suggests their heightened sensitivity to the MST1R inhibitor MGCD-265 (Fig. 2C).